TMEM37 and chronic myelogenous leukemia, BCR-ABL1 positive: In comparison to healthy, CML patients had significantly expanded anti-PR1 responses (median % of total TCR repertoire 0.743% vs 0.595%, log2FC = 0.320, P = 4.9 × 10−5, two-sided Mann-Whitney test, Fig. 5e).